ARCHIVES

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Congress Orders Programs In Nutrition Research; Cancer Act Extension Beefs Up NCI Chief’s Authority

July 12, 1974

When Doctors Take Work Home: Houston Burglary Points to Security Breach

June 29, 2012

Biotech Firm Plans Custom Clinical trials In USSR for Drug Firms

August 18, 1989

OTA Report Concludes Prostate Screening Not Demonstrated To Save Lives

June 2, 1995

NCI Advisory Group, Other Cancer Meetings

May 29, 1987

In Brief: AACR Grants Record Number Of Awards To Young Investigators; Kersey Leads ASBMT

April 24, 1998